
AngioDynamics wins FDA IDE for feasibility study of NanoKnife in BPH
AngioDynamics (Nasdaq:ANGO) announced today that it received FDA investigational device exemption (IDE) to initiate the RELIEF study.

AngioDynamics (Nasdaq:ANGO) announced today that it received FDA investigational device exemption (IDE) to initiate the RELIEF study.

Researchers at the Medical University of Vienna have described a mechanism in metastatic colorectal cancer that has received little attention to date: A key target of existing therapies, the so-called epidermal growth factor receptor (EGFR), is likely to affect more than just the cancer cells themselves. The study shows that EGFR also influences certain immune cells in the tumor microenvironment—and thereby helps determine how effectively the body’s own defenses can combat the tumor.

The largest and longest clinical trial of its kind has found that resurfacing the kneecap during total knee replacement is likely to be the most cost-effective approach for patients and health care systems over the long term.

A study led by researchers at Children’s Hospital of Philadelphia (CHOP) demonstrates a new method of using decellularized cartilage with patient-specific cells to help enlarge pediatric airways narrowed as a result of severe subglottic stenosis.

Now, a vibrating pill could help doctors determine whether a patient with anorexia nervosa may have a higher risk of relapse, according to a new study by UCLA Health.

A new University of Otago—Ōtākou Whakaihu Waka-led study has put its own spin on Pavlov’s dog experiment, shining a light on how our brain learns new things. The study, “The superior colliculus gates dopamine responses to conditioned stimuli in visual classical conditioning” is published in Nature

A team has identified an experimental molecule capable of “reprogramming” the brain’s immune cells to restore part of their protective function against Alzheimer’s disease. The study, published in the journal Cell Death and Disease, shows that the compound, called OLE, helps microglia enclose and contain beta-amyloid plaques, reducing their size and toxicity.